Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 2.600
-0.230 (-8.13%)
May 9, 2025, 4:14 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 69.39 million as of May 9, 2025. Its market cap has decreased by -73.70% in one year.
Market Cap
69.39M
Enterprise Value
67.59M
Revenue
44.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 69.39M, a decrease of -89.62%. That is a compound annual growth rate of -41.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 69.39M | 49.47% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.57B |
| Nordhealth AS | 2.80B |
| Photocure ASA | 1.33B |
| Vistin Pharma ASA | 1.09B |
| Nykode Therapeutics AS | 898.66M |
| Hofseth BioCare ASA | 871.49M |
| Omda AS | 849.02M |
| Gentian Diagnostics ASA | 848.23M |